Neurol. praxi. 2023;24(5):330-336 | DOI: 10.36290/neu.2023.026

Diagnostic imaging methods in neurooncology

MUDr. Martin Vítovec, MUDr. et Ing. Radek Tupý, Ph.D., prof. MUDr. Jiří Ferda, Ph.D.
Klinika zobrazovacích metod, Lékařská fakulta Univerzity Karlovy v Plzni, Fakultní nemocnice Plzeň

The article provides an overview of the possibilities of imaging methods in neurooncology. Firstly the most accessible examination using computed tomography and secondly dominant magnetic resonance imaging and its multiparametric imaging thanks to its advanced submodalities. The article also shows potential and usage of hybrid methods that allow the combination of advantages of metabolic imaging with advantages of magnetic resonance imaging.

Keywords: computed tomography, magnetic resonance imaging, multiparametric imaging, hybrid methods.

Received: March 9, 2023; Revised: May 2, 2023; Accepted: May 2, 2023; Prepublished online: May 2, 2023; Published: October 30, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vítovec M, Ing.Radek Tupý ME, Ferda J. Diagnostic imaging methods in neurooncology. Neurol. praxi. 2023;24(5):330-336. doi: 10.36290/neu.2023.026.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bagadia A, Purandare H, Misra BK, Gupta S. Application of magnetic resonance tractography in the perioperative planning of patients with eloquent region intra­‑axial brain lesions. J Clin Neurosci. 2011;18:633-639. Go to original source... Go to PubMed...
    2. Bizzi A, Blasi V, Falini A, et al. Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping. Radiology. 2008;248:579-589. Go to original source... Go to PubMed...
    3. Byrnes TJ, Barrick TR, Bell BA, Clark CA. Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo. NMR Biomed. 2011;24:54-60. Go to original source... Go to PubMed...
    4. Calli C, Kitis O, Yunten N, et al. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol. 2006; 58(3):394e403. Go to original source... Go to PubMed...
    5. Stegmayr C, Stoffels G, Filß Ch, et al. Current trends in the use of O-(2-[18 F]fluoroethyl)-L­‑tyrosine ([18 F]FET) in neurooncology. Nuclear Medicine and Biology. 2021;92:78-84. Go to original source... Go to PubMed...
    6. Field AS, Wu YC, Alexander AL. Principal diffusion direction in peritumoral fiber tracts: color map patterns and directional statistics. Ann N Y Acad Sci. 2005;1064:193e201. Go to original source... Go to PubMed...
    7. Guo AC, Cummings TJ, Dash RC, et al. Lymphomas and highgrade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology. 2002;224(1):177e183. Go to original source... Go to PubMed...
    8. Roberts HC, Roberts TPL, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast­‑enhanced MR imaging: correlation with histologic grade. American Journal of Neuroradiology. 2000;21(5):891-899.
    9. Hayashida Y, Hirai T, Morishita S, et al. Diffusion­‑weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol. 2006; 27:1419-1425.
    10. Anna K. Heye, Ross D. Culling, Maria del C. Valdés Hernández, Michael J. Thrippleton, Joanna M. Wardlaw, Assessment of blood-brain barrier disruption using dynamic contrast­‑enhanced MRI. A systematic review. NeuroImage: Clinical. 2014;6:262-274, ISSN 2213-1582. Go to original source... Go to PubMed...
    11. Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2003;49:223-232. Go to original source... Go to PubMed...
    12. Inoue T, Ogasawara K, Beppu T, et al. Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas. Clin Neurol Neurosurg. 2005;107(3):174e180. Go to original source... Go to PubMed...
    13. Kickingereder P, Wiestler B, Graf M, et al. Evaluation of dynamic contrast­‑enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2015;121:373-380. Go to original source... Go to PubMed...
    14. Kitajima M, Hirai T, Shigematsu Y, et al. Comparison of 3D FLAIR, 2D FLAIR, and 2D T2-Weighted MR Imaging of Brain Stem Anatomy. AJNR Am J Neuroradiol. 2012;33(5):922-927. Go to original source... Go to PubMed...
    15. Krabbe K, Gideon P, Wagn P, et al. MR diffusion imaging of human intracranial tumours. Neuroradiology. 1997;39(7):483e489. Go to original source... Go to PubMed...
    16. Ku MC, Waiczies S, Niendorf T, Pohlmann A. Assessment of Blood Brain Barrier Leakage with Gadolinium­‑Enhanced MRI. Methods Mol Biol. 2018;1718:395-408. doi: 10.1007/978-1-4939-7531-0_23. PMID: 29341021. Go to original source... Go to PubMed...
    17. Kwock L, Smith JK, Castillo M, et al. Clinical applications of proton MR spectroscopy in oncology. Technol Cancer Res Treat. 2002;1:17-28. Go to original source... Go to PubMed...
    18. Kwong KK, Belliveau JW, Chesler DA, et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A. 1992;89:5675-5679. Go to original source... Go to PubMed...
    19. Lee YY, Bruner JM, Van Tassel P, Libshitz HI. Primary central nervous system lymphoma: CT and pathologic correlation. AJR Am J Roentgenol. 1986;147:747-752. Go to original source... Go to PubMed...
    20. Lee YY, Van Tassel P. Intracranial oligodendrogliomas: imaging findings in 35 untreated cases. AJR Am J Roentgenol. 1989;152:361-369. Go to original source... Go to PubMed...
    21. Lin K, Kazmi KS, Law M, Babb J, Peccerelli N, Pramanik BK. Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first­‑pass dynamic perfusion CT imaging. AJNR Am J Neuroradiol. 2007;28:1292-8. Go to original source... Go to PubMed...
    22. Mori S, van Zijl PC. Fiber tracking: principles and strategies - a technical review. NMR Biomed. 2002;15:468-480. Go to original source... Go to PubMed...
    23. Mugler J. Optimized three-dimensional fast-spin-echo MRI. J. Magn. Reson. Imaging. 2014;39(4):745-767. Go to original source... Go to PubMed...
    24. Okamoto K, Ito J, Ishikawa K, et al. Diffusion­‑weighted echoplanar MR imaging in differential diagnosis of brain tumors and tumor­‑like conditions. Eur Radiol. 2000;10(8):1342e1350. Go to original source... Go to PubMed...
    25. Patel P, Baradaran H, Delgado D, et al. MR perfusion­‑weighted imaging in the evaluation of high­‑grade gliomas after treatment: a systematic review and meta­‑analysis. Neuro Oncol. 2017;19(1):118-127. doi: 10.1093/neuonc/now148. Go to original source... Go to PubMed...
    26. Pillai JJ. The evolution of clinical functional imaging during the past 2 decades and its current impact on neurosurgical planning. AJNR Am J Neuroradiol. 2010;31:219-225. Go to original source... Go to PubMed...
    27. Price SJ, Jena R, Burnet NG, et al. Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image­‑guided biopsy study. AJNR Am J Neuroradiol. 2006;27:1969-1974.
    28. Romano A, D'Andrea G, Minniti G, et al. Pre­‑surgical planning and MR­‑tractography utility in brain tumour resection. Eur Radiol. 2009;19:2798-2808. Go to original source... Go to PubMed...
    29. Mills SJ, Patankar TA, Haroon HA, et al. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? American Journal of Neuroradiology. 2006;27(4):853-858.
    30. Rohde S, Maßberg M, Reinhardt J, et al. Impact of Technical and Morphological Factors on the Precision of Software­‑Based MR Tumor Volumetry: a Phantom Study. Rofo. 2008;180(7):654-661. Go to original source... Go to PubMed...
    31. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast­‑enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging JMRI. 1999;10:223-232. Go to original source...
    32. Toh CH, Chen YL, Hsieh TC, et al. Glioblastoma multiforme with diffusion­‑weighted magnetic resonance imaging characteristics mimicking primary brain lymphoma. Case report. J Neurosurg. 2006;105(1):132e135. Go to original source... Go to PubMed...
    33. Ulmer JL, Salvan CV, Mueller WM, et al. The role of diffusion tensor imaging in establishing the proximity of tumor borders to functional brain systems: implications for preoperative risk assessments and postoperative outcomes. Technol Cancer Res Treat. 2004;3:567-576. Go to original source... Go to PubMed...
    34. White ML, Zhang Y, Yu F, Jaffar Kazmi SA. Diffusion tensor MR imaging of cerebral gliomas: evaluating fractional anisotropy characteristics. AJNR Am J Neuroradiol. 2011;32:374-381. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.